NaviGate Cardiac Structures Inc. (NCSI) announced that a first-in-human implant of its catheter-guided, mitral-valved stent into a beating heart was performed successfully in a 53-year-old male patient presenting with severe 4+ mitral regurgitation (MR).

CIRS ATOM phantoms are a full line of anthropomorphic, cross sectional dosimetry phantoms designed to investigate organ dose, whole body effective dose as well as verification of delivery of therapeutic radiation doses.

ATOM is the only line of dosimetry phantoms to range in sizes from newborn to adult. Six models are available: newborn, 1-year, 5-year and 10-year old pediatric phantoms as well as adult male and female phantoms.

Boston Heart Diagnostics announced the launch of StatinSmart, an at-home saliva laboratory developed test that analyzes the SLCO1B1 (Solute Carrier Organic Anion Transporter 1B1) gene for a variant known to increase an individual's risk for developing statin-induced myopathy.

Boston Scientific announced the first implants of the Watchman FLX left atrial appendage closure (LAAC) device

Carestream has obtained U.S. Food and Drug Administration (FDA) clearance for diagnostic reading of electrocardiogram (ECG) waveforms on desktop displays and mobile tablets using its Vue Motion universal viewer.

At this year’s scientific assembly and annual meeting of the Radiological Society of North America (RSNA), ContextVision will be demonstrating its wide range of leading 2-D/3-D/4-D imaging enhancement software solutions for ultrasound.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now